Efficacy and Safety Study of Xyotax to Treat Prostate Cancer
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Xyotax, a conjugate of the taxane drug
paclitaxel, is effective in the treatment of prostate cancer that is no longer responsive to
hormone therapy.
Phase:
Phase 2
Details
Lead Sponsor:
The Methodist Hospital Research Institute The Methodist Hospital System